2016 Conference Support for the 5th International Conference on Engineering Frontiers in Pediatric and Congenital Heart Disease

2016年第五届儿科和先天性心脏病工程前沿国际会议的会议支持

• 批准号: 1613079
• 负责人: Alain Kassab
• 金额: $ 2万
• 依托单位: The University of Central Florida Board of Trustees
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-03-01 至 2017-02-28
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=1613079&HistoricalAwards=false
• 关键词: 2016; Conference; Support; 5th; International

Congenital heart disease (CHD) is the leading cause of death for infants born with birth defects and represents 1% of births in the USA, and according to the NIH that is 8 out of every 1,000 newborns. Successful treatment of CHD offers opportunities to improve quality of life for individuals afflicted with this disease with consequent benefit to society. Over 1 million adults in the USA are living with congenital heart defects. The field of engineering application in congenital heart disease has undergone an explosive growth in both application and development nationally worldwide over the past decades. The cutting edge problems that are the subject of this conference are at the interface of engineering and medicine. The 5th International Conference on Engineering Frontiers in Pediatric and Congenital Heart Disease brings together leading professionals in both the engineering and medical disciplines to foster collaboration between these two communities in the study of treatment of congenital diseases. The close interaction of medical doctors and engineering researchers is critical to achieving advances in the treatment of this disease and to bring engineering to bear as an aid to physicians in understanding the complex blood flow and resulting from this congenital disease, in improving and developing diagnostic tools, and in improving treatment planning. This conference aims to impact improved treatment and understanding of this age-related disease that afflicts a significant segment of the US population with the consequent improvement in patient quality of life and reduction of medical costs associated with CHD treatment. This conference also aims to expose and engage emerging researchers in a common forum to exchange the latest in developments in the field and to further establish domestic and international collaborations. These researchers will be recruited from the pool of current and recent Ph.D. graduates, Post-Docs and Fellows. The PIs will preferentially offer support to members of underrepresented groups involved in biomedical engineering research in pediatric and congenital heart disease, thus upholding the national goal of engaging underrepresented groups into the STEM disciplines. This conference as well provides successful role models for women who have established vibrant research programs and labs in this field, for instance, there are two female researcher professors on their international organizing and steering committees. The conference offers many more opportunities, invited speakers, session chairs, and panel discussions, for beginning and established female engineering and medical researchers engaged in CHD research to network at the national and international level, and thereby actively promotes recruitment of females in STEM. It is vital to maintain the continuity of the International Conference on Engineering Frontiers in Pediatric and Congenital Heart Disease series that effectively brings together leading researchers in engineering and medicine who are engaged in cutting edge research in pediatric and congenital heart disease. The conference provides a forum to exchange of ongoing and latest breakthrough research, to expose innovative ideas, and to build research collaborations between leading researchers from across the USA and Europe. Moreover, the conference promotes new researchers becoming engaged in the field through the Young Investigator podium speaker program and its young investigator poster competition. This series of conferences has historically attracted both USA and international participants. Specifically, through this award, NSF will support: (1) Invited Speaker Program: support travel expenses of ten (10) distinguished university faculty and medical professionals who are foremost experts in congenital heart disease to attend Frontiers 2016 and deliver invited podium presentations on their on-going research and (2) Travel of Young Investigators and Graduate Students: the PIs will support Young Investigators (4 non-UCF investigators) who will deliver podium (oral) presentations and graduate students (6 non-UCF students) to participate in Frontiers 2016. Young investigators present podium talks and PhD students participate in the poster presentation and competition. There will be a poster competition with awards for 1st-3rd place judged by a panel selected from the invited speakers. Moreover, there will be a panel-led debate to address the pros and cons of the issue: will CFD ever reach the bedside and should it? The conference organizers have made every effort and have achieved the goal of keeping a 50/50 balance between engineering faculty and medical professionals in all invited and keynote lectures as well as panel-led debates. The PIs have also secured a special issue of the World Journal for Pediatric and Congenital Heart Surgery to collect a series of selected papers from the invited speakers as a follow-up to the conference. The NSF funds will leverage financial sponsorship that has been secured from academic and two medical institutions in support the conference program.

先天性心脏病（CHD）是出生缺陷婴儿死亡的主要原因，占美国出生婴儿的1%，根据NIH的数据，每1,000名新生儿中有8名先天性心脏病。CHD的成功治疗为患有这种疾病的个体提供了改善生活质量的机会，从而造福于社会。在美国，超过100万成年人患有先天性心脏病。在过去的几十年里，先天性心脏病的工程应用领域在世界范围内的应用和发展都经历了爆炸性的增长。作为本次会议主题的前沿问题是工程和医学的接口。第五届儿科和先天性心脏病工程前沿国际会议汇集了工程和医学学科的领先专业人士，以促进这两个社区在先天性疾病治疗研究方面的合作。医学医生和工程研究人员的密切互动是至关重要的，以实现在这种疾病的治疗进展，并使工程承担作为一种援助，医生在了解复杂的血液流动，并导致这种先天性疾病，在改善和发展诊断工具，并在改善治疗计划。本次会议旨在改善对这种年龄相关疾病的治疗和理解，这种疾病困扰着美国人口的很大一部分，从而改善患者的生活质量，降低与CHD治疗相关的医疗费用。本次会议还旨在在一个共同的论坛上展示和吸引新兴的研究人员，以交流该领域的最新发展，并进一步建立国内和国际合作。这些研究人员将从现有和最近的博士库中招募。毕业生、博士后和研究员。PI将优先为参与儿科和先天性心脏病生物医学工程研究的代表性不足的群体成员提供支持，从而维护让代表性不足的群体参与STEM学科的国家目标。这次会议也为在这一领域建立了充满活力的研究方案和实验室的妇女提供了成功的榜样，例如，在其国际组织和指导委员会中有两名女研究员教授。会议提供了更多的机会，邀请演讲者，会议主席和小组讨论，为开始和建立女性工程和医学研究人员从事冠心病研究在国家和国际层面的网络，从而积极促进女性在干招聘。保持儿科和先天性心脏病工程前沿国际会议系列的连续性至关重要，该会议有效地汇集了从事儿科和先天性心脏病前沿研究的工程和医学领域的领先研究人员。该会议提供了一个论坛，以交流正在进行的和最新的突破性研究，揭示创新的想法，并建立来自美国和欧洲的领先研究人员之间的研究合作。 此外，会议通过青年研究者讲台演讲者计划和青年研究者海报竞赛促进新的研究人员参与该领域。这一系列会议历来吸引了美国和国际与会者。具体而言，通过该奖项，NSF将支持：（1）特邀演讲者计划：支持十（10）名杰出的大学教师和医疗专业人员的差旅费，他们是先天性心脏病的最重要的专家，参加Frontiers 2016，并就他们正在进行的研究提供邀请的讲台演讲，以及（2）年轻研究人员和研究生的差旅费：PI将支持年轻的研究人员（4名非UCF研究人员），他们将提供讲台（口头）演讲和研究生（6名非UCF学生）参加Frontiers 2016。年轻的研究人员发表演讲，博士生参加海报展示和比赛。将有一个海报比赛与奖项的第一至第三名由一个小组从邀请的发言者选出的判断。 此外，将有一个小组主导的辩论，以解决这个问题的利弊：将CFD永远到达床边，应该吗？会议组织者尽了一切努力，并实现了在所有邀请和主题演讲以及小组辩论中保持工程学院和医学专业人员之间50/50平衡的目标。作为会议的后续行动，PI还获得了《世界儿科和先天性心脏手术杂志》的特刊，以收集受邀演讲者的一系列精选论文。NSF的资金将利用学术和两个医疗机构的财政赞助来支持会议计划。